paricalcitol
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
19 FDA-registered drug labelers
AbbVie Inc.
AbbVie Ireland NL B.V.
Accord Healthcare, Inc.
Amneal Pharmaceuticals LLC
Aurobindo Pharma Limited
Bionpharma Inc.
Bryant Ranch Prepack
Catalent Pharma Solutions, LLC
Chongqing Huapont Pharmaceutical Co Ltd
Dr. Reddy's Laboratories Limited
Eugia US LLC
Formosa Laboratories, Inc.
MARKSANS PHARMA LIMITED
Neuland Laboratories Limited
Patheon Softgels Inc.
Sai Life Sciences Limited
Sigma-Aldrich Corporation
TIME CAP LABORATORIES, INC
West-Ward Pharmaceuticals Corp
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Paricalcitol
- •Zemplar
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Paricalcitol Capsule
10/07/2025Chemical Identity
CAS131918-61-1
PubChem CID5281104
DTXSIDDTXSID4048640
FormulaC27H44O3
Mol. Weight416.6 g/mol
SMILESCC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C
Data Sources
52811042026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/paricalcitol/cids/JSON
Archive: data/sources/pubchem_name/paricalcitol.json
CAS 131918-61-12026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 131918-61-12026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json